191 related articles for article (PubMed ID: 9516889)
1. Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas.
Harnden P; Southgate J
J Clin Pathol; 1997 Dec; 50(12):1032-3. PubMed ID: 9516889
[TBL] [Abstract][Full Text] [Related]
2. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
Oliva E; Amin MB; Jimenez R; Young RH
Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
[TBL] [Abstract][Full Text] [Related]
3. [Epidermoid carcinoma of the urinary tract. Immunohistochemical study].
Salas Valien JS; García Díez F; González Morán MA; Rodríguez López JA; Guerreiro González R
Arch Esp Urol; 1990; 43(9):973-6. PubMed ID: 1708980
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of cytokeratin 17 in transitional cell carcinomas of the human urinary tract.
Guelstein VI; Tchipysheva TA; Ermilova VD; Troyanovsky SM
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(1):1-5. PubMed ID: 7691361
[TBL] [Abstract][Full Text] [Related]
5. FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma.
Warrick JI; Kaag M; Raman JD; Chan W; Tran T; Kunchala S; Shuman L; DeGraff D; Chen G
Virchows Arch; 2017 Sep; 471(3):337-345. PubMed ID: 28721490
[TBL] [Abstract][Full Text] [Related]
6. Synchronous squamous cell carcinoma of the kidney, squamous cell carcinoma of the ureter, and sarcomatoid carcinoma of the urinary bladder: a case report.
Terada T
Pathol Res Pract; 2010 Jun; 206(6):379-83. PubMed ID: 19766408
[TBL] [Abstract][Full Text] [Related]
7. Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer.
Gaisa NT; Braunschweig T; Reimer N; Bornemann J; Eltze E; Siegert S; Toma M; Villa L; Hartmann A; Knuechel R
Virchows Arch; 2011 Mar; 458(3):301-12. PubMed ID: 21136076
[TBL] [Abstract][Full Text] [Related]
8. [Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas].
Moll R; Laufer J; Wu XR; Sun TT
Verh Dtsch Ges Pathol; 1993; 77():260-5. PubMed ID: 7511294
[TBL] [Abstract][Full Text] [Related]
9. Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry.
Lopez-Beltran A; Requena MJ; Alvarez-Kindelan J; Quintero A; Blanca A; Montironi R
J Clin Pathol; 2007 Mar; 60(3):332-5. PubMed ID: 16882698
[TBL] [Abstract][Full Text] [Related]
10. [Non-urothelial tumors of the urinary tract].
Mikuz G
Verh Dtsch Ges Pathol; 1993; 77():180-98. PubMed ID: 7511278
[TBL] [Abstract][Full Text] [Related]
11. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
[TBL] [Abstract][Full Text] [Related]
13. Behavior of epithelial differentiation antigens (carcinoembryonic antigen, epithelial membrane antigen, keratin and cytokeratin) in transitional cell carcinomas of the bladder.
Sánchez-Fernández de Sevilla MC; Morell-Quadreny L; Gil-Salom M; Pérez-Bacete M; Fenollosa-Entrena B; Llombart-Bosch A
Urol Int; 1992; 48(1):14-9. PubMed ID: 1376008
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry of cytokeratin proteins in squamous and transitional cell lesions of the urinary tract.
Tungekar MF; Gatter KC; Al-Adnani MS
J Clin Pathol; 1988 Dec; 41(12):1288-96. PubMed ID: 2465317
[TBL] [Abstract][Full Text] [Related]
15. Cystic renal cell and squamous cell carcinoma of single kidney with concurrent transitional cell carcinoma of ipsilateral ureter and urinary bladder.
Charles RS; Wein AJ; Wilczynski S; Tomaszewski JE; Hanno PM
Urology; 1992 May; 39(5):470-2. PubMed ID: 1580043
[TBL] [Abstract][Full Text] [Related]
16. Urothelial carcinoma with squamous differentiation--the pathologists׳ perspective.
Gellert LL; Warrick J; Al-Ahmadie HA
Urol Oncol; 2015 Oct; 33(10):437-43. PubMed ID: 26321057
[TBL] [Abstract][Full Text] [Related]
17. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
Samaratunga H; Khoo K
Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
[TBL] [Abstract][Full Text] [Related]
18. The L1 antigen and squamous metaplasia in the bladder.
Tungekar MF; Heryet A; Gatter KC
Histopathology; 1991 Sep; 19(3):245-50. PubMed ID: 1717359
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
[TBL] [Abstract][Full Text] [Related]
20. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
